Impact of diabetes mellitus on recurrence and progression in patients with non-muscle invasive bladder carcinoma: A retrospective cohort study

International Journal of Urology

Volumn 18, Issue 11, 2011, Pages 769-776

  Hwang, Eu Chang ^a   Kim, Young Jung ^a   Hwang, In Sang ^a   Hwang, Jun Eul ^a   Jung, Seung Il ^a   Kwon, Dong Deuk ^a   Park, Kwangsung ^a   Ryu, Soo Bang ^a  

^a Chonnam National University Medical School   (South Korea)

Author keywords

Diabetes mellitus; Progression; Recurrence; Urinary bladder neoplasm

Indexed keywords

CREATININE; HEMOGLOBIN A1C;

AGED; ARTICLE; BLADDER CARCINOMA; CANCER GROWTH; CANCER INVASION; CANCER PATIENT; CANCER RECURRENCE; CANCER SIZE; CANCER SURGERY; CANCER SURVIVAL; CIGARETTE SMOKING; CLINICAL ASSESSMENT; CONTROLLED STUDY; CREATININE BLOOD LEVEL; DIABETES MELLITUS; DISEASE ASSOCIATION; DISEASE SEVERITY; FEMALE; GENDER; GLYCEMIC CONTROL; HEMOGLOBIN BLOOD LEVEL; HUMAN; HYPERTENSION; MAJOR CLINICAL STUDY; MALE; NON MUSCLE INVASIVE BLADDER CANCER; PREOPERATIVE PERIOD; PRIORITY JOURNAL; PROGRESSION FREE SURVIVAL; RETROSPECTIVE STUDY; TRANSURETHRAL RESECTION;

AGED; CARCINOMA IN SITU; CREATININE; DIABETES COMPLICATIONS; DIABETES MELLITUS; DISEASE PROGRESSION; DISEASE-FREE SURVIVAL; FEMALE; HEMOGLOBIN A, GLYCOSYLATED; HUMANS; KAPLAN-MEIER ESTIMATE; MALE; MIDDLE AGED; MULTIVARIATE ANALYSIS; NEOPLASM RECURRENCE, LOCAL; PROPORTIONAL HAZARDS MODELS; RETROSPECTIVE STUDIES; SEX FACTORS; SMOKING; URINARY BLADDER NEOPLASMS;

EID: 80355144449     PISSN: 09198172     EISSN: 14422042     Source Type: Journal    
DOI: 10.1111/j.1442-2042.2011.02845.x     Document Type: Article

References (33)

1. Donat SM. Evaluation and follow-up strategies for superficial bladder cancer. Urol. Clin. North Am. 2003; 30: 765-76.
2. Heney NM, Ahmed S, Flanagan MJ etal. Superficial bladder cancer: progression and recurrence. J. Urol. 1983; 130: 1083-6.
3. Larsson SC, Orsini N, Wolk A. Diabetes mellitus and risk of colorectal cancer: a meta-analysis. J. Natl. Cancer Inst. 2005; 97: 1679-87.
4. Larsson SC, Mantzoros CS, Wolk A. Diabetes mellitus and risk of breast cancer: a meta-analysis. Int. J. Cancer 2007; 121: 856-62.
5. Friberg E, Orsini N, Mantzoros CS, Wolk A. Diabetes mellitus and risk of endometrial cancer: a meta-analysis. Diabetologia 2007; 50: 1365-74.
6. El-Serag HB, Hampel H, Javadi F. The association between diabetes and hepatocellular carcinoma: a systematic review of epidemiologic evidence. Clin. Gastroenterol. Hepatol. 2006; 4: 369-80.
7. Kravchick S, Gal R, Cytron S etal. Increased incidence of diabetes mellitus in the patients with transitional cell carcinoma of urinary bladder. Pathol. Oncol. Res. 2001; 7: 56-9.
8. Ng Y, Husain I, Waterfall N. Diabetes mellitus and bladder cancer: an epidemiological relationship? Pathol. Oncol. Res. 2003; 9: 30-1.
9. Larsson SC, Orsini N, Brismar K, Wolk A. Diabetes mellitus and risk of bladder cancer: a meta-analysis. Diabetologia 2006; 49: 2819-23.
10. Larsson SC, Andersson SO, Johansson JE, Wolk A. Diabetes mellitus, body size and bladder cancer risk in a prospective study of Swedish men. Eur. J. Cancer 2008; 44: 2655-60.
11. Sobin LH, Wittekind C. Urinary bladder. In: International Union Against Cancer (UICC). TNM: Classification of Malignant Tumors. Wiley-Liss, New York, 1997; 187-90.
12. Miyamoto H, Miller JS, Fajardo DA, Lee TK, Netto GJ, Epstein JI. Non-invasive papillary urothelial neoplasms: the 2004 WHO/ISUP classification system. Pathol. Int. 2010; 60: 1-8.
13. Tripathi A, Folsom AR, Anderson KE. Risk factors for urinary bladder carcinoma in postmenopausal women. The Iowa Women's Health Study. Cancer 2002; 95: 2316-23.
14. Coughlin SS, Calle EE, Teras LR, Petrelli J, Thun MJ. Diabetes mellitus as a predictor of cancer mortality in a large cohort of US adults. Am. J. Epidemiol. 2004; 159: 1160-7.
15. Jee SH, Ohrr H, Sull JW, Yun JE, Ji M, Samet JM. Fasting serum glucose level and cancer risk in Korean men and women. JAMA 2005; 293: 194-202.
16. Swerdlow AJ, Laing SP, Qiao Z etal. Cancer incidence and mortality in patients with insulin-treated diabetes: a UK cohort study. Br. J. Cancer 2005; 92: 2070-5.
17. Zendehdel K, Nyren O, Ostenson CG, Adami HO, Ekbom A, Ye W. Cancer incidence in patients with type 1 diabetes mellitus: a population-based cohort study in Sweden. J. Natl Cancer Inst. 2003; 95: 1797-800.
18. Rousseau MC, Parent ME, Pollak MN, Siemiatycki J. Diabetes mellitus and cancer risk in a population-based case-control study among men from Montreal, Canada. Int. J. Cancer 2006; 118: 2105-9.
19. Chang CH, Song JM. Effect of smoking on bladder cancer as a single risk factor. Korean J Urol. 2004; 45: 1-6 (in Korean).
20. Migaldi M, Rossi G, Maiorana A etal. Superficial papillary urothelial carcinomas in young and elderly patients: a comparative study. BJU Int. 2004; 94: 311-16.
21. Joo JS, Kim JS, Jung SI etal. The prognostic significance of elevated serum creatinine for the recurrence and progression in superficial bladder tumors. Korean J Urol. 2007; 48: 927-32 (in Korean).
22. Wu CH, Wu TY, Li CC, Lui MT, Chang KW, Kao SY. Impact of diabetes mellitus on the prognosis of patients with oral squamous cell carcinoma: a retrospective cohort study. Ann. Surg. Oncol. 2010; 17: 2175-83.
23. Siddiqui AA, Spechler SJ, Huerta S, Dredar S, Little BB, Cryer B. Elevated HbA1c is an independent predictor of aggressive clinical behavior in patients with colorectal cancer: a case-control study. Dig. Dis. Sci. 2008; 53: 2486-94.
24. Hong SK, Lee ST, Kim SS etal. Significance of preoperative HbA1c level in patients with diabetes mellitus and clinically localized prostate cancer. Prostate 2009; 69: 820-6.
25. Kim HS, Presti JC Jr, Aronson WJ etal. Glycemic control and prostate cancer progression: results from the SEARCH database. Prostate 2010; 70: 1540-6.
26. Richardson LC, Pollack LA. Therapy insight: influence of type 2 diabetes on the development, treatment and outcomes of cancer. Nat. Clin. Pract. Oncol. 2005; 2: 48-53.
27. Attia N, Caprio S, Jones TW etal. Changes in free insulin-like growth factor-1 and leptin concentrations during acute metabolic decompensation in insulin withdrawn patients with type 1 diabetes. J. Clin. Endocrinol. Metab. 1999; 84: 2324-8.
28. Butler AA, Blakesley VA, Poulaki V, Tsokos M, Wood TL, LeRoith D. Stimulation of tumor growth by recombinant human insulin-like growth factor-I (IGF-I) is dependent on the dose and the level of IGF-I receptor expression. Cancer Res. 1998; 58: 3021-7.
29. Singh AK, Mo W, Dunea G, Arruda JA. Effect of glycated proteins on the matrix of glomerular epithelial cells. J. Am. Soc. Nephrol. 1998; 9: 802-10.
30. Lokeshwar VB, Lokeshwar VB, Young MJ etal. Identification of bladder tumor-derived hyaluronidase: its similarity to HYAL1. Cancer Res. 1999; 59: 4464-70.
31. Chen HC, Chen CA, Guh JY, Chang JM, Shin SJ, Lai YH. Altering expression of alpha3beta1 integrin on podocytes of human and rats with diabetes. Life Sci. 2000; 67: 2345-53.
32. Lipponen PK, Eskelinen MJ. Reduced expression of E-cadherin is related to invasive disease and frequent recurrence in bladder cancer. J. Cancer Res. Clin. Oncol. 1995; 121: 303-8.
33. Joshi N, Caputo GM, Weitekamp MR, Karchmer AW. Infections in patients with diabetes mellitus. N. Engl. J. Med. 1999; 341: 1906-12.